English
Back
Download
Log in to access Online Inquiry
Back to the Top

Towards the sector conference, a gradual recovery trend is expected.

$TransMedics (TMDX.US)$ The market share has not been taken away, and as the market is recovering in October, it is hoped to hear about developments post-November at the sector conference. Is it a buy? If it goes very smoothly, aim for a recovery to $100 in the next earnings announcement? Conversely, if shy for two consecutive quarters, it could also break below $70.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
See Original
Report
15K Views
Comment
Sign in to post a comment
    1
    Follower
    0
    Following
    6
    Visitors
    Follow